Immunohistochemical localization of insulin-like growth factor binding protein 2 in the central nervous system of SOD1G93A transgenic mice
- 154 Downloads
In the present study, we performed immunohistochemical studies to investigate the changes of insulin-like growth factor binding protein 2 (IGFBP2) in the central nervous system of SOD1G93A mutant transgenic mice as an in vivo model of amyotrophic lateral sclerosis (ALS). Decreased immunoreactivity for IGFBP2 was observed in the cerebral cortex, hippocampus and brainstem of SOD1G93A transgenic mice. In the cerebral cortex, the number of IGFBP2-positive cells was decreased in the somatomotor area, somatosensory area, auditory area, visual area, entorhinal area, piriform area and prefrontal area. In the hippocampal formation, IGFBP2 immunoreactivity was significantly decreased in the CA1-3 areas and the dentate gyrus. In the brainstem, few IGFBP2-immunoreactive cells were observed in the medullary and pontine reticular formation, vestibular nucleus, trigeminal motor nucleus, facial nucleus, hypoglossal nucleus and raphe nucleus. In the spinal cord, IGFBP2 immunoreactivity was not significantly decreased in SOD1G93A transgenic mice. This study showing decreased IGFBP2 in different brain regions of SOD1G93A transgenic mice may provide clues for understanding differential susceptibility of neural structures in ALS.
KeywordsAmyotrophic lateral sclerosis (ALS) SOD1G93A transgenic mice Insulin-like growth factor binding protein 2 (IGFBP2) Cerebral cortex Hippocampus Immunohistochemistry
This work was supported by Grant NO. 21-2005-029-0 from the SNUH Research Fund.
- Chung YH, Joo KM, Shin CM, Lee YJ, Shin DH, Lee KH, Cha CI (2003) Immunohistochemical study on the distribution of insulin-like growth factor I (IGF-I) receptor in the central nervous system of SOD1G93A mutant transgenic mice. Brain Res 994:253–259. doi: 10.1016/j.brainres.2003.09.047 CrossRefPubMedGoogle Scholar
- Dore S, Krieger C, Kar S, Quirion R (1996) Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients. Brain Res Mol Brain Res 41:128–133. doi: 10.1016/0169-328X(96)00081-2 CrossRefPubMedGoogle Scholar
- Kang DW, Chung YH, Lee JC, Bang JS, Kim D, Kim SS, Kim KY, Lee WB, Cha CI (2008) Immunohistochemical study on the distribution of insulin-like growth factor-binding protein 4 in the central nervous system of SOD1G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Ann Anat 190:502–509. doi: 10.1016/j.aanat.2008.08.001 CrossRefPubMedGoogle Scholar
- Kerkhoff H, Hassan SM, Troost D, Van Etten RW, Veldman H, Jennekens FG (1994) Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis. Acta Neuropathol 87:411–421. doi: 10.1007/BF00313611 CrossRefPubMedGoogle Scholar